Cruz, Gabriela
Ramos-Cartagena, Jeslie M.
Torres-Russe, José L.
Colón-López, Vivian
Ortiz-Ortiz, Karen J.
Pericchi, Luis
Deshmukh, Ashish A.
Ortiz, Ana Patricia
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R25CA240120, 2U54CA096297–18, R25CA240120, 2U54CA096297–18, 2U54CA096297–18, 2U54CA096297–18, 2U54CA096297–18, R25CA240120)
Article History
Received: 19 May 2023
Accepted: 27 September 2023
First Online: 6 October 2023
Declarations
:
: This study was approved by the Institutional Review Board of the University of Puerto Rico Comprehensive Cancer Center and followed the Declaration of Helsinki (Protocol number: 2019–07-10).All participants provided telephone-based informed consent before they participated in the study.
: N/A.
: Dr. Ortiz reported receiving grants from the National Institutes of Health and Merck during the conduct of the study and reported consulting fees from Merck & Co outside the submitted work. Dr. Ortiz-Ortiz reported receiving grants from the Centers for Disease Control and Prevention National Program of Cancer Registries, the National Cancer Institute, Abbvie Corp, and Merck & Co outside the submitted work. Dr. Colón-López reported receiving consulting fees from Merck & Co outside the submitted work. All the other authors do not have competing interest.